Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC)

Sarah R. Verhoeff, S. Es, E. Boon, E. van Helden, L. Angus, S. Elias, S. Oosting, E. Aarntzen, A. Brouwers, S. Heskamp, O. S. Hoekstra, H. M. Verheul, A. A. M. Van der Veldt, E. G. E. de Vries, O. Boerman, W. T. A. van der Graaf, W. J. G. Oyen, C. M. L. van Herpen

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Article number888P
Pages (from-to)viii314-viii315
Number of pages2
JournalAnnals of Oncology
Issue numberSuppl.8
Publication statusPublished - Oct-2018
Event43rd ESMO Congress (ESMO) - Munich, Germany
Duration: 19-Oct-201823-Oct-2018

Cite this